Dexmedetomidine Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Dexmedetomidine Hydrochloride Injection (injection) from Mylan Institutional, A Viatris Company with status Current. The shortage was first posted on Apr 10, 2020.
Shortage details
- Status
- Current
- Company
- Mylan Institutional, A Viatris Company
- Package NDC
- 67457-924-50
- Dosage Form
- Injection
- Presentation
- Dexmedetomidine Hydrochloride, Injection, 200 ug/50 mL (NDC 67457-924-50)
- Initial Posting
- Apr 10, 2020